Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial

BACKGROUND: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity disorder (ADHD), is associated with serious adverse effects like arrhythmia. Evidence on the association of ADHD with immune and oxidant-antioxidant imbalances offers potential for antioxidant and/or i...

Descripción completa

Detalles Bibliográficos
Autores principales: Verlaet, Annelies A. J., Ceulemans, Berten, Verhelst, Helene, Van West, Dirk, De Bruyne, Tess, Pieters, Luc, Savelkoul, Huub F. J., Hermans, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370458/
https://www.ncbi.nlm.nih.gov/pubmed/28351412
http://dx.doi.org/10.1186/s13063-017-1879-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370458/
https://www.ncbi.nlm.nih.gov/pubmed/28351412
http://dx.doi.org/10.1186/s13063-017-1879-6

Ejemplares similares